Ok here is the relevant info from the release in N
Post# of 36537
(Total Views: 278)
Posted On: 02/03/2021 9:57:08 AM
Ok here is the relevant info from the release in Nov:
$50 million licensing deal for the Ii-Key platform to develop vaccines for infectiousdiseases and cancer
− Deal includes first contract for Ii-Key- SARS-CoV-2 vaccine against COVID-19 in Chinawith a $5 million upfront licensing fee, 100% funding for manufacturing, development and commercial registration and a $20 million success fee for approval Ii-Key- SARSCoV-2 vaccine in China
Here is most recent PR:
- China Licensing & Research Agreement advances with $100,000
payment guarantee and $1 million advance on development funding
So my interpretation. We've received the $100k. This $1m is not part of the $5m advance on licensing but part of the "100% funding for manufacturing, development and commercial registration "
I see this as bullish. My initial take was negative.
Still disappointed not to see any reference to IPO
$50 million licensing deal for the Ii-Key platform to develop vaccines for infectiousdiseases and cancer
− Deal includes first contract for Ii-Key- SARS-CoV-2 vaccine against COVID-19 in Chinawith a $5 million upfront licensing fee, 100% funding for manufacturing, development and commercial registration and a $20 million success fee for approval Ii-Key- SARSCoV-2 vaccine in China
Here is most recent PR:
- China Licensing & Research Agreement advances with $100,000
payment guarantee and $1 million advance on development funding
So my interpretation. We've received the $100k. This $1m is not part of the $5m advance on licensing but part of the "100% funding for manufacturing, development and commercial registration "
I see this as bullish. My initial take was negative.
Still disappointed not to see any reference to IPO
(3)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼